1.
Stein A, Petersen V, Schulze M, Seraphin J, Hoeffkes H-G, Valdix AR, et al. Bevacizumab plus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: Results from a large German community-based observational cohort study. AO [Internet]. 2015 Feb. 7 [cited 2026 May 18];54(2):171-8. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/25813